IPS, from first choice to question marks
For a long time patients talked about IPS as the safest pair of hands. Fast dispatch, predictable delivery, low drama. Recent choices have moved that story in the wrong direction. Patients describe packaging that is easy to spot, delivery friction, and clogged inboxes. The effect is a slide from trusted leader to avoid list. This is how a market leader seals its own fate, and how to reverse it.
Evidence extracts from the Reddit thread
“Loads of people are which is such a shame, Integro and IPS used to be faultless, now I dread an order.”Source: r/ukmedicalcannabis thread
“TBF, the label does always say IPS Pharma anyway, but in small print. It is all trackable, so when it goes missing you feel sick.”Source: r/ukmedicalcannabis thread
“I had the same today and thought it was bizarre. The posties know they are carrying controlled items.”Source: r/ukmedicalcannabis thread
“Free advertisement to steal my package? I’ve never had the tape on my box before.”Source: r/ukmedicalcannabis thread
“Let me know what they reply, for some reason I can’t email them, it keeps bouncing back.”Source: r/ukmedicalcannabis thread
“Is it any different than my usual NHS prescription coming in pharmacy labeled packaging?”Source: r/ukmedicalcannabis thread
“I’ve just emailed to find out more because now I’m curious. Do they want to bait up patients and maybe even lose some over this?”Source: r/ukmedicalcannabis thread
“You are aware IPS doesn’t just do medical cannabis, right. They do general pharmacy services and other specials and controlled drugs too.”Source: r/ukmedicalcannabis thread
Then versus now
| Then, what patients expected | Now, what patients report |
|---|---|
| Plain outer packaging, nothing that hints at sender or contents | Recognisable labels or tape, couriers that seem to know the sender |
| Fast, predictable dispatch and delivery slots that hold | Late or missing parcels, anxiety about weekend gaps and depot limbo |
| Responsive inbox with clear routes for service and complaints | Confused email routes, slow replies, claims of blocked or restricted channels |
| Single chain of accountability from clinic to door | Buck passing between clinic and pharmacy, no owner of continuity |
That is the reputation shift in one picture. From first choice to question marks.
What changed, according to patients
- Packaging and discretion, outer packaging is easy to recognise. Patients call this the opposite of discreet. Privacy at the door matters.
- Courier pattern risk, reports that certain couriers recognise the parcels. More loss and delay stories follow.
- Communication breakdown, confusion over inboxes and poor complaint flow. People want a single front door with ticket numbers.
- System edges show, clinics and the pharmacy act like separate islands. Patients fall down the gap in the middle.
All of this comes from a large public discussion captured in mid September 2025. Hundreds of comments, same themes on loop. We grouped and de duplicated the reports to see the pattern, then focused on patient impact.
Why this matters
Discretion is not a nice to have. It is safety and dignity. Late parcels break dosing plans. Jammed inboxes turn simple fixes into full stress. The combined effect is risk to continuity of treatment. That risk lands hardest on disabled patients, which makes this a reasonable adjustments issue as well as a logistics one.
How a leader loses trust
- Make the outer box distinctive, even by accident. People notice.
- Stick to one courier even when loss rates spike. People wait.
- Hide the complaints route in a maze of inboxes. People give up.
- Tell patients to chase the clinic, then tell them to chase the pharmacy. People stop trusting both.
None of this needs to be fatal. It becomes fatal when the pattern is denied or left to drift.
Documented case timeline
The sequence below relates to our own case handler at IPS. We present it as a factual timeline. We are not asserting causation.
- Case handler: identified as Ms Aaisha Rahman, an IPS manager responsible for our case. Based on her publicly visible LinkedIn profile, she appears to have started at IPS in early summer 2025. That period coincides with a rise in patient reports of issues across the UK. We note the timing without asserting causation and invite clarification.
- Reasonable adjustments: written communications were requested repeatedly due to disability. Phone contact was not requested.
- Curaleaf notification: days before the IPS phone attempt, Curaleaf emailed to state that IPS would not process further prescriptions. IPS did not inform us directly and responsibility to notify was passed to Curaleaf. Screenshot.
- Phone attempt: IPS later attempted to call. The call was missed. This was contrary to repeated written communication requests.
- Settlement context: shortly before the Curaleaf email, the author proposed a small settlement figure after Ms Rahman asked basic questions about the scope of the subject access request.
We hold timestamped emails and captures that support the sequence above. If IPS or Curaleaf provide additional context or corrections, we will publish a fair summary.
The 30 day fix
- Packaging audit, remove any sender hints on the outer. Test with people outside the business. Pass or fail, no spin.
- Courier rotation plan, if loss or delay crosses a red line, switch. Publish the rule and stick to it.
- Single front door, one service inbox, one complaints inbox, both with auto replies, ticket numbers, and target response times.
- Clinic pharmacy handshake, a written process for supply breaks. One owner, one action plan, one update to the patient.
- Transparency update, a short post with the changes, the metrics you will track, and the date you will report back.
The fix is not rocket science. It is parcel science, inbox hygiene, and grown up ownership.
Steps patients can take today
- Photograph the outer packaging, redact personal details, keep dates and tracking IDs.
- Log delivery events with screenshots, note failed attempts and depot scans.
- Use one published email route for service issues, cc the clinic when supply risk is real.
- Ask for reasonable adjustments, state what you need and why, such as a tighter slot or alternate pickup.
- Escalate in order, service inbox, complaints, then external oversight if the process fails.
Method and evidence base
We reviewed a large, active public discussion from mid September 2025 and direct reader submissions. Comments were grouped by theme, duplicates removed, and the analysis focused on patient impact and patterns over anecdotes.
- Primary thread: “IPS WTF???” on r/ukmedicalcannabis
- Documented case artefact: Curaleaf withdrawal email (screenshot)
If you have additional evidence, send timestamped details to [email protected].
Right of reply
IPS and Curaleaf are invited to respond with clarifications, corrective action, or data that shows improvement. We will publish a fair summary. Email [email protected] with the subject line IPS reply.
Closing view
Leaders stay leaders by fixing small problems fast. Patients once called IPS the best. Recent steps have chipped away at that status. The next steps decide the story from here.
Be First to Comment